4579 · RaQualia Pharma Inc. · Financials
Market Cap
17.36B JPY
Shares
26.03M
Volume · Nov 12
259.6K
Avg daily vol (3M)
170.78K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Net Income
273.12M
+155.2%
FY2025
Operating Cash Flow
-354.43M
-295.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| JPY | 483.72M | -213.38M | -337.37M | 866.24M | 707.86M |
| JPY | 437.95M | -357.73M | -294.05M | 851.01M | 880.58M |
| JPY | 164.83M | 137.3M | 29.61M | 127.62M | 124.79M |
| JPY | 273.12M | -495.03M | -323.66M | 723.39M | 755.79M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.